My reading from previous ASX releases is that the requirement was for 150 ppaedeatric patients in its Confirmatory Trial... refer to ASX release No 483 23/11/2010
Any recruitement above the 150 was a bonus and backup in case of non approval in some countries... as has proven to be the case.
kippax